Janux Therapeutics

JANX

Market cap $979M

JANX Hedge Fund Activity: Q1 2026 in Review

190 of the 8,125 institutional investors tracked by Wall St. Rank reported a position in Janux Therapeutics (JANX) for Q1 2026, worth a combined $828M — down 3.7% from $860M a quarter earlier.

Buyers outnumbered sellers: 46 funds opened new JANX positions and 28 closed out — a net gain of 18 holders — while 66 added to existing stakes and 54 trimmed.

The largest buyer was BlackRock, adding an estimated $18.6M. The largest seller was State Street, cutting an estimated $19.1M.

• 190 institutional investors held Janux Therapeutics (JANX) as of Q1 2026, up from 176 in Q4 2025.
• Funds reported $828M of Janux Therapeutics stock for Q1 2026, down 3.7% quarter-over-quarter.
• 46 funds opened new Janux Therapeutics positions in Q1 2026 and 28 closed out, a net change of +18 holders.
• The largest Janux Therapeutics buyer in Q1 2026 was BlackRock, an estimated $18.6M added.
• The largest Janux Therapeutics seller in Q1 2026 was State Street, an estimated $19.1M sold.

Based on aggregated 13F filings for Q1 2026.